SHR-A1912

SHR-A1912 · Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-A1912, covering 2025-11-18 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma [Phase 3]

See pricing